An Observational Feasibility Study for the Production of a Patient Specific Neoantigen Cancer Vaccine in Patients with Advanced Cancer

Gender
Any

Age Group
Any

At a Glance

IRB#IRB18-0463

Lead PhysicianDaniel Catenacci

Collaborator(s)N/A

EligibilityNot Recruiting